Gene Correction for SCID-X1 in Long-Term Hematopoietic Stem Cells

Nature Communications - United Kingdom
doi 10.1038/s41467-019-09614-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Challenges in Vector and Trial Design Using Retroviral Vectors for Long-Term Gene Correction in Hematopoietic Stem Cell Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Runx1 Loss Minimally Impacts Long-Term Hematopoietic Stem Cells

PLoS ONE
Multidisciplinary
2011English

Fetal Hepatic Progenitors Support Long-Term Expansion of Hematopoietic Stem Cells

Experimental Hematology
Cancer ResearchGeneticsHematologyMolecular BiologyCell Biology
2013English

Correction of Murine SCID-X1 by Lentiviral Gene Therapy Using a Codon-Optimized IL2RG Gene and Minimal Pretransplant Conditioning

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

93. Generation of Gene-Corrected, Vector- And Reprogramming Factor-Free iPS Cells From SCID-X1 Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

Correction: Biophysical Regulation of Hematopoietic Stem Cells

Biomaterials Science
Materials ScienceBiomedical Engineering
2014English

Preclinical Development of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1)

Blood
BiochemistryImmunologyCell BiologyHematology
2016English

Long-Term Multilineage Engraftment of Autologous Genome-Edited Hematopoietic Stem Cells in Nonhuman Primates

Blood
BiochemistryImmunologyCell BiologyHematology
2016English

Mobilization of Long-Term Reconstituting Hematopoietic Stem Cells in Mice by Recombinant Human Interleukin 7

Journal of Experimental Medicine
MedicineAllergyImmunology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy